European Union medicines chief is 'firmly convinced' AstraZeneca's COVID-19 vaccine is worth getting

AstraZeneca vaccine
(Image credit: Asanka Ratnayake/Getty Images)

Sweden joined its Scandinavian neighbors and several other European countries on Tuesday in suspending use of the Oxford-AstraZeneca COVID-19 vaccine, citing reports of blood clotting among vaccine recipients. Thirteen European Union countries — including Germany, France, Italy, and Spain — have suspended use of the AstraZeneca vaccine until a review, expected Thursday, from the EU's drug regulator, the European Medicines Agency. EMA chief Emer Cooke urged those nations to resume vaccinations.

"We are still firmly convinced that the benefits of the AstraZeneca vaccine in preventing COVID-19 with its associated risk of hospitalization and death outweigh the risk of the side effects," Cooke said Tuesday. "At present there is no indication that vaccination has caused these conditions," but "this is a serious concern and it does need serious and detailed scientific evaluation." The World Health Organization and AstraZeneca also say there's no evidence the vaccine increases risk of blood clots.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
Peter Weber, The Week US

Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.